127
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort

, , , , , & show all
Pages 1639-1655 | Published online: 23 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Kristian Brat, Michal Svoboda, Jaromir Zatloukal, Marek Plutinsky, Eva Volakova, Patrice Popelkova, Barbora Novotna, Tomas Dvorak & Vladimir Koblizek. (2023) Prognostic Properties of the GOLD 2023 Classification System. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 661-667.
Read now
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton & Afisi S Ismaila. (2023) Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 719-731.
Read now
Christiaan Theunisse, Huibert H Ponssen, Netty T C de Graaf, Maaike Scholten-Bakker, Sten P Willemsen & David Cheung. (2021) The Effects of Low Pressure Domiciliary Non-Invasive Ventilation on Clinical Outcomes in Patients with Severe COPD Regardless Having Hypercapnia. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 817-824.
Read now
Kate Petrie, Brett G Toelle, Richard Wood-Baker, Graeme P Maguire, Alan L James, Michael Hunter, David P Johns, Guy B Marks, Johnson George & Michael J Abramson. (2021) Undiagnosed and Misdiagnosed Chronic Obstructive Pulmonary Disease: Data from the BOLD Australia Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 467-475.
Read now
Åsa Athlin, Maaike Giezeman, Mikael Hasselgren, Scott Montgomery, Karin Lisspers, Björn Ställberg, Christer Janson & Josefin Sundh. (2021) Prediction of Mortality Using Different COPD Risk Assessments – A 12-Year Follow-Up. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 665-675.
Read now
Roberto Bernabeu-Mora, M Piedad Sánchez-Martínez, Joaquina Montilla-Herrador, Silvana L Oliveira-Sousa, Mariano Gacto-Sánchez & Francesc Medina-Mirapeix. (2020) 2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1519-1527.
Read now

Articles from other publishers (8)

Janwillem Kocks, António Jorge Ferreira, Per Bakke, Onno C. P. van Schayck, Heikki Ekroos, Nikolaos Tzanakis, Stéphane Soulard, Monika Haaksma-Herczegh, Montserrat Mestres-Simon, Malena Águila-Fuentes & Didier Cataldo. (2023) Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study. npj Primary Care Respiratory Medicine 33:1.
Crossref
E.E. Yazar, B. Yi..itba..E.Y. Niksarl..o..lu, M. Bayraktaro..lu & S. Kul. (2023) Is group C really needed as a separate group from D in COPD? A single-center cross-sectional study. Pulmonology 29:3, pages 188-193.
Crossref
Mark Dransfield, Ravi Kalhan & Daiana Stolz. (2023) Pushing (for) GOLD. European Respiratory Journal 61:4, pages 2300366.
Crossref
Qing Song, Ling Lin, Wei Cheng, Xue-Shan Li, Yu-Qin Zeng, Cong Liu, Min-Hua Deng, Dan Liu, Zhi-Ping Yu, Xin Li, Li-Bing Ma, Yan Chen, Shan Cai & Ping Chen. (2023) Clinical–functional characteristics and risk of exacerbation and mortality among more symptomatic patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMJ Open 13:3, pages e065625.
Crossref
Qingtao Meng, Jiajia Wang, Jian Cui, Bin Li, Shenshen Wu, Jun Yun, Michael Aschner, Chengshuo Wang, Luo Zhang, Xiaobo Li & Rui Chen. (2022) Prediction of COPD acute exacerbation in response to air pollution using exosomal circRNA profile and Machine learning. Environment International 168, pages 107469.
Crossref
Jieun Kang, Jae Seung Lee, Sei Won Lee, Jung Bok Lee & Yeon-Mok Oh. (2021) Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials. Respiratory Research 22:1.
Crossref
J. Betancourt-Peña, M.C. Artunduaga-Landazabal, M.P. Gil-Ramírez, K. León Atoy & J.C. Ávila-Valencia. (2021) Comparación de variables clínicas, capacidad funcional, ansiedad/depresión y calidad de vida en pacientes con EPOC de acuerdo a la clasificación GOLD 2018. Fisioterapia 43:1, pages 19-29.
Crossref
Jacek Polański, Mariusz Chabowski, Natalia Świątoniowska-Lonc, Grzegorz Mazur & Beata Jankowska-Polańska. 2020. Health and Medicine. Health and Medicine 81 91 .